Progression-free survival of up to 8 months of an advanced intrahepatic cholangiocarcinoma patient treated with apatinib: a case report.
Onco Targets Ther
; 10: 5237-5242, 2017.
Article
in En
| MEDLINE
| ID: mdl-29138576
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Observational_studies
/
Prognostic_studies
Language:
En
Journal:
Onco Targets Ther
Year:
2017
Document type:
Article
Country of publication:
New Zealand